3-(7-Methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl)-acrylic acid, 1g

2-Amino-3-fluoroisonicotinic acid, 97.0%, 1g

trans,trans-3,4-Difluoro-4'-(4'-pentylbicyclohexyl-4-yl)biphenyl>98.0%(GC)5g

4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 250mg

N-(4-Bromopyridin-2-yl)acetamide, 95.0%, 1g

1-Boc-2-methyl-piperidin-5-one, 98.0%, 5g

(4S,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride, 98%, 250mg

2-(2-amino-1,3-thiazol-4-yl)ethanol hydrochloride, 95.0%, 1g

7-Amino-2,3-dihydroinden-1-one, 95.0%, 100mg

ROTI®Cell RPMI-1640

Morpholino(quinoxalin-6-yl)methanone, 95.0%, 100mg

(S)-2-(((tert-Butyldiphenylsilyl)oxy)methyl)pyrrolidine, 95%, 100mg

(S)-2-(1-(tert-Butoxycarbonyl)piperidin-3-yl)acetic acid, 95.0%, 1g